Image Source: Nevro
Innovation continues to thrive in the medical field. The rapid aging of the industrialized world’s population bodes well for rising demand. Let’s look at a promising med tech idea, which we believe offers explosive growth in the field of Neuromodulation. It’s a risky one though.
By Alexander J. Poulos
Introduction
We are interested in the growth prospects of Nevro (NVRO), a med tech idea specializing in the field of Neuromodulation. Neuromodulation is the use of electrical impulses to stimulate the nervous system. Nevro’s key product is the Senza Spinal Cord Stimulation (SCS) system, which offers relief from chronic pain by stimulating the nervous tissue found in the spinal cord to reduce or entirely block the perception of pain. We believe a credible case can be made for wider overall potential adoption especially in the light of the continued focus on the opioid epidemic in America.
